Suppr超能文献

促肾上腺皮质激素释放因子与囊泡谷氨酸转运体在大鼠中缝背核轴突终末内的共定位

Co-localization of corticotropin-releasing factor and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleus.

作者信息

Waselus Maria, Van Bockstaele Elisabeth J

机构信息

Department of Neurosurgery, Thomas Jefferson University, Farber Institute for Neurosciences, 900 Walnut Street, Suite 417, Philadelphia, PA 19107, USA.

出版信息

Brain Res. 2007 Oct 12;1174:53-65. doi: 10.1016/j.brainres.2007.08.014. Epub 2007 Aug 14.

Abstract

Electrophysiological, microdialysis and behavioral studies support a modulatory role for corticotropin-releasing factor (CRF) in regulating the dorsal raphe nucleus (DRN)-serotonin (5-HT) system. CRF and 5-HT are implicated in the pathophysiology of depression, thus neuroanatomical substrates of CRF-DRN-5-HT interactions are of interest. Identification of co-transmitters within DRN CRF axon terminals is important for elucidating the complex effects underlying CRF afferent regulation of DRN neurons. This study investigated whether CRF-labeled axon terminals within the DRN contain immunoreactivity for vesicular glutamate transporters (isoforms vGlut1 and vGlut2) indicative of the excitatory neurotransmitter glutamate. Dual immunohistochemistry for CRF and either vGlut1 or vGlut2 was conducted within the same tissue section and immunofluorescence results indicated patterns of immunoreactivity consistent with previous reports. Abundant vGlut1- and vGlut2-immunoreactivity was found in puncta exhibiting a largely uniform distribution, whereas CRF-immunoreactivity was localized to topographically distributed varicose processes within the DRN. Profiles containing both CRF- and either vGlut1- or vGlut2-immunoreactivity were apparent in the DRN. Electron microscopy confirmed that immunoreactivity for CRF and vGlut1 was localized primarily to separate axon terminals in the DRN, with a subset co-localizing CRF and vGlut1. Examination of CRF and vGlut2 immunoreactivities in the DRN indicated that CRF and vGlut2 were found within the same axon terminal more frequently than CRF and vGlut1. Overall, these anatomical findings suggest that CRF may function, in part, with the excitatory neurotransmitter glutamate in the modulation of neuronal activity in the DRN.

摘要

电生理、微透析和行为学研究支持促肾上腺皮质激素释放因子(CRF)在调节中缝背核(DRN)-5-羟色胺(5-HT)系统中发挥调节作用。CRF和5-HT与抑郁症的病理生理学有关,因此CRF-DRN-5-HT相互作用的神经解剖学基础备受关注。鉴定DRN中CRF轴突终末内的共递质对于阐明CRF传入调节DRN神经元的复杂效应很重要。本研究调查了DRN内CRF标记的轴突终末是否含有囊泡谷氨酸转运体(亚型vGlut1和vGlut2)的免疫反应性,这表明存在兴奋性神经递质谷氨酸。在同一组织切片内对CRF与vGlut1或vGlut2进行双重免疫组织化学,免疫荧光结果显示的免疫反应模式与先前报道一致。在显示出大致均匀分布的小点中发现了丰富的vGlut1和vGlut2免疫反应性,而CRF免疫反应性则定位于DRN内按地形分布的曲张突起。在DRN中明显可见同时含有CRF和vGlut1或vGlut2免疫反应性的轮廓。电子显微镜证实,CRF和vGlut1的免疫反应性主要定位于DRN中不同的轴突终末,有一部分CRF和vGlut1共定位。对DRN中CRF和vGlut2免疫反应性的检查表明,CRF和vGlut2在同一轴突终末内出现的频率比CRF和vGlut1更高。总体而言,这些解剖学发现表明,CRF可能部分地与兴奋性神经递质谷氨酸共同发挥作用,调节DRN中的神经元活动。

相似文献

引用本文的文献

1
CRF regulates pain sensation by enhancement of corticoaccumbal excitatory synaptic transmission.
Mol Psychiatry. 2024 Jul;29(7):2170-2184. doi: 10.1038/s41380-024-02488-7. Epub 2024 Mar 7.
2
Changed Synaptic Plasticity in Neural Circuits of Depressive-Like and Escitalopram-Treated Rats.
Int J Neuropsychopharmacol. 2015 Apr 21;18(10):pyv046. doi: 10.1093/ijnp/pyv046.
3
Glutamatergic input is selectively increased in dorsal raphe subfield 5-HT neurons: role of morphology, topography and selective innervation.
Eur J Neurosci. 2011 Dec;34(11):1794-806. doi: 10.1111/j.1460-9568.2011.07882.x. Epub 2011 Nov 18.
4
Collateralized dorsal raphe nucleus projections: a mechanism for the integration of diverse functions during stress.
J Chem Neuroanat. 2011 Jul;41(4):266-80. doi: 10.1016/j.jchemneu.2011.05.011. Epub 2011 May 30.
5
Glutamatergic drive of the dorsal raphe nucleus.
J Chem Neuroanat. 2011 Jul;41(4):247-55. doi: 10.1016/j.jchemneu.2011.04.004. Epub 2011 Apr 27.
7
Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction.
Brain Res. 2010 Feb 16;1314:29-37. doi: 10.1016/j.brainres.2009.09.100. Epub 2009 Oct 1.

本文引用的文献

1
Stress sensitivity and the development of affective disorders.
Horm Behav. 2006 Nov;50(4):529-33. doi: 10.1016/j.yhbeh.2006.06.033. Epub 2006 Aug 8.
2
VGLUTs: 'exciting' times for glutamatergic research?
Neurosci Res. 2006 Aug;55(4):343-51. doi: 10.1016/j.neures.2006.04.016. Epub 2006 Jun 9.
3
Selective cortical VGLUT1 increase as a marker for antidepressant activity.
Neuropharmacology. 2005 Nov;49(6):890-900. doi: 10.1016/j.neuropharm.2005.06.017. Epub 2005 Aug 18.
4
Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment.
J Neurochem. 2005 Aug;94(4):875-83. doi: 10.1111/j.1471-4159.2005.03192.x. Epub 2005 Jun 30.
9
Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression.
J Am Acad Child Adolesc Psychiatry. 2004 Mar;43(3):341-8. doi: 10.1097/00004583-200403000-00017.
10
Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain.
Neuroscience. 2004;123(4):983-1002. doi: 10.1016/j.neuroscience.2003.10.039.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验